Addictive Behaviors Research Center, Department of Psychology, University of Washington, Seattle, Washington, USA.
Subst Abus. 2009 Oct-Dec;30(4):295-305. doi: 10.1080/08897070903250084.
The current study is the first randomized-controlled trial evaluating the feasibility and initial efficacy of an 8-week outpatient Mindfulness-Based Relapse Prevention (MBRP) program as compared to treatment as usual (TAU). Participants were 168 adults with substance use disorders who had recently completed intensive inpatient or outpatient treatment. Assessments were administered pre-intervention, post-intervention, and 2 and 4 months post-intervention. Feasibility of MBRP was demonstrated by consistent homework compliance, attendance, and participant satisfaction. Initial efficacy was supported by significantly lower rates of substance use in those who received MBRP as compared to those in TAU over the 4-month post-intervention period. Additionally, MBRP participants demonstrated greater decreases in craving, and increases in acceptance and acting with awareness as compared to TAU. Results from this initial trial support the feasibility and initial efficacy of MBRP as an aftercare approach for individuals who have recently completed an intensive treatment for substance use disorders.
本研究是首个评估 8 周门诊正念预防复发（MBRP）方案相对于常规治疗（TAU）的可行性和初步疗效的随机对照试验。参与者为 168 名近期完成强化住院或门诊治疗的物质使用障碍成年人。在干预前、干预后以及干预后 2 个月和 4 个月进行评估。MBRP 的可行性通过持续的家庭作业依从性、出勤率和参与者满意度得到证明。在干预后 4 个月的时间里，与接受 TAU 的患者相比，接受 MBRP 的患者物质使用的发生率明显较低，这支持了其初步疗效。此外，与 TAU 相比，MBRP 参与者的渴望程度降低，接受度和意识行动增加。这项初步试验的结果支持 MBRP 作为近期完成强化物质使用障碍治疗的个体的一种康复方法的可行性和初步疗效。
